148 related articles for article (PubMed ID: 34387029)
21. Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library.
Sahin D; Taflan SO; Yartas G; Ashktorab H; Smoot DT
Asian Pac J Cancer Prev; 2018 Apr; 19(4):927-932. PubMed ID: 29693344
[TBL] [Abstract][Full Text] [Related]
22. Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen.
Bai R; Yuan C
Aging Dis; 2022 Jul; 13(4):1267-1277. PubMed ID: 35855340
[TBL] [Abstract][Full Text] [Related]
23. Detection of Kita-Kyushu Lung Cancer Antigen-1, a Cancer/Testis Antigen, in the Stomach Close to a Cancerous Condition.
Otsuka T; Fukuyama T; Futawatari N; Tahara K; Watanabe M; Ichiki Y; Soeno T; Takahashi Y; Yamazaki H; Fujimori Y; Ohshiro T; Kobayashi N; Kida M; Koizumi W; Kusano C
J Cancer; 2022; 13(14):3526-3532. PubMed ID: 36484013
[No Abstract] [Full Text] [Related]
24. A Cy5.5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living mice.
Chen K; Yap LP; Park R; Hui X; Wu K; Fan D; Chen X; Conti PS
Amino Acids; 2012 Apr; 42(4):1329-37. PubMed ID: 21212998
[TBL] [Abstract][Full Text] [Related]
25. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
[TBL] [Abstract][Full Text] [Related]
26. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.
Larimer BM; Thomas WD; Smith GP; Deutscher SL
Mol Imaging Biol; 2014 Aug; 16(4):449-58. PubMed ID: 24550054
[TBL] [Abstract][Full Text] [Related]
27. [MDR-reversing effect of short peptide binding specifically to multidrug-resistant gastric cancer cells].
Wang P; Ding J; Lin T; Han S; Cao SS; Ge FL; An GQ; Li R; Lei T; Bai FH; Fan DM
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):258-61. PubMed ID: 17760250
[TBL] [Abstract][Full Text] [Related]
28. Screening and Identification of a Phage Display Derived Peptide That Specifically Binds to the CD44 Protein Region Encoded by Variable Exons.
Zhang D; Jia H; Li W; Hou Y; Lu S; He S
J Biomol Screen; 2016 Jan; 21(1):44-53. PubMed ID: 26423339
[TBL] [Abstract][Full Text] [Related]
29. Characterization of In Vivo Selected Bacteriophage for the Development of Novel Tumor-Targeting Agents with Specific Pharmacokinetics and Imaging Applications.
Newton-Northup J; Deutscher SL
Methods Mol Biol; 2017; 1572():445-465. PubMed ID: 28299705
[TBL] [Abstract][Full Text] [Related]
30. PET/CT Imaging of NSCLC with a α
Flechsig P; Lindner T; Loktev A; Roesch S; Mier W; Sauter M; Meister M; Herold-Mende C; Haberkorn U; Altmann A
Mol Imaging Biol; 2019 Oct; 21(5):973-983. PubMed ID: 30671741
[TBL] [Abstract][Full Text] [Related]
31. Isolation of a colon tumor specific binding peptide using phage display selection.
Kelly KA; Jones DA
Neoplasia; 2003; 5(5):437-44. PubMed ID: 14670181
[TBL] [Abstract][Full Text] [Related]
32. [Screening and Identification of the Peptides Specifically Binding to
Human Non-small Cell Lung Cancer NCI-H1299 Cells].
Zuo Q; Guo C; Fan W; Yang X; Zhang F
Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1023-1030. PubMed ID: 33357309
[TBL] [Abstract][Full Text] [Related]
33. targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide.
Du B; Han H; Wang Z; Kuang L; Wang L; Yu L; Wu M; Zhou Z; Qian M
Mol Cancer Res; 2010 Feb; 8(2):135-44. PubMed ID: 20145035
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Novel ITGα
Altmann A; Sauter M; Roesch S; Mier W; Warta R; Debus J; Dyckhoff G; Herold-Mende C; Haberkorn U
Clin Cancer Res; 2017 Aug; 23(15):4170-4180. PubMed ID: 28468949
[No Abstract] [Full Text] [Related]
35. A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.
Matsuo AL; Tanaka AS; Juliano MA; Rodrigues EG; Travassos LR
J Mol Med (Berl); 2010 Dec; 88(12):1255-64. PubMed ID: 20802991
[TBL] [Abstract][Full Text] [Related]
36. Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer.
Liang S; Lin T; Ding J; Pan Y; Dang D; Guo C; Zhi M; Zhao P; Sun L; Hong L; Shi Y; Yao L; Liu J; Wu K; Fan D
J Mol Med (Berl); 2006 Sep; 84(9):764-73. PubMed ID: 16763842
[TBL] [Abstract][Full Text] [Related]
37. Screening of a specific peptide binding to esophageal squamous carcinoma cells from phage displayed peptide library.
Ma C; Li C; Jiang D; Gao X; Han J; Xu N; Wu Q; Nie G; Chen W; Lin F; Hou Y
Mol Cell Probes; 2015 Jun; 29(3):182-9. PubMed ID: 25886968
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
39. High-throughput Pyrosequencing of a phage display library for the identification of enriched target-specific peptides.
Rahim A; Coutelle C; Harbottle R
Biotechniques; 2003 Aug; 35(2):317-20, 322, 324. PubMed ID: 12951773
[TBL] [Abstract][Full Text] [Related]
40. Affinity peptide developed by phage display selection for targeting gastric cancer.
Zhang WJ; Sui YX; Budha A; Zheng JB; Sun XJ; Hou YC; Wang TD; Lu SY
World J Gastroenterol; 2012 May; 18(17):2053-60. PubMed ID: 22563192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
